speb/financial-data huggingface dataset:
AGEN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 23339000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 180000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 183000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 12518000.00
AGEN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 183000.00
AGEN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -7978000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Common Stock: 329000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -274137000.00
AGEN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 8965000.00
AGEN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
AGEN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 24238000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 24390000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Assets: 133950000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1178000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Debt: 10611000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 11789000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 45000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 45000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 287132000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 146000.00
AGEN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3031000.00
AGEN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3031000.00
AGEN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 32858000.00
AGEN income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.94
AGEN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 63860000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Non Current: 15043000.00
AGEN income_statement (quarterly, 2025-09-30) — EBIT: 77081000.00
AGEN income_statement (quarterly, 2025-09-30) — EBITDA: 80112000.00
AGEN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -20000.00
AGEN cash_flow (quarterly, 2025-09-30) — End Cash Position: 5170000.00
AGEN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 6683000.00
AGEN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -14737000.00
AGEN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 100924000.00
AGEN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 318000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1560000.00
AGEN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10860000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Goodwill: 24092000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 27214000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 71180000.00
AGEN income_statement (quarterly, 2025-09-30) — Gross Profit: 5997000.00
AGEN income_statement (quarterly, 2025-09-30) — Interest Expense: 13170000.00
AGEN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 13170000.00
AGEN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 258000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Invested Capital: -239927000.00
AGEN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 76000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 30482000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 30482000.00
AGEN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 8965000.00
AGEN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
AGEN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 10383000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 23599000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 33982000.00
AGEN cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
AGEN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -678000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 30482000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Minority Interest: -6731000.00
AGEN income_statement (quarterly, 2025-09-30) — Minority Interests: 3000.00
AGEN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 8965000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Net Debt: 30752000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Income: 63914000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 63860000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 63911000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 63914000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 63914000.00
AGEN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 63911000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 63911000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Interest Income: -13170000.00
AGEN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
AGEN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -678000.00
AGEN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -678000.00
AGEN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -13170000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Net PPE: 24014000.00
AGEN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 76000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -301351000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 15043000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -21130000.00
AGEN income_statement (quarterly, 2025-09-30) — Normalized Income: -16067180.00
AGEN balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 5725000.00
AGEN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -14737000.00
AGEN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -100917000.00
AGEN income_statement (quarterly, 2025-09-30) — Operating Income: -4863000.00
AGEN income_statement (quarterly, 2025-09-30) — Operating Revenue: 1087000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 32814429.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1195000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 10465000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 165619000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1560000.00
AGEN income_statement (quarterly, 2025-09-30) — Other Gand A: 10860000.00
AGEN income_statement (quarterly, 2025-09-30) — Other Income Expense: 81944000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3122000.00
AGEN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -16618000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3188000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 192502000.00
AGEN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -19298000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Other Properties: 71180000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Payables: 85289000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 109679000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
AGEN income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 54000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 885000.00
AGEN income_statement (quarterly, 2025-09-30) — Pretax Income: 63911000.00
AGEN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 78000.00
AGEN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
AGEN balance_sheet (quarterly, 2025-09-30) — Receivables: 6263000.00
AGEN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 24238000.00
AGEN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3031000.00
AGEN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -678000.00
AGEN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
AGEN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -2172187000.00
AGEN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
AGEN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 76000.00
AGEN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10860000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Share Issued: 32814429.00
AGEN income_statement (quarterly, 2025-09-30) — Special Income Charges: 100924000.00
AGEN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3242000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -274137000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -301351000.00
AGEN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 21260820.00
AGEN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
AGEN balance_sheet (quarterly, 2025-09-30) — Total Assets: 233891000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -250538000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Total Debt: 45771000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -280868000.00
AGEN income_statement (quarterly, 2025-09-30) — Total Expenses: 35098000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 514759000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 99941000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 227627000.00
AGEN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4545000.00
AGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items: 101242000.00
AGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 101242000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Working Capital: -153182000.00
AGEN income_statement (annual, 2025-12-31) — +Operating Expense: 54392000.00
AGEN income_statement (quarterly, 2025-12-31) — +Operating Expense: 12295000.00
AGEN income_statement (annual, 2025-12-31) — +Total Revenue: 114196000.00
AGEN income_statement (quarterly, 2025-12-31) — +Total Revenue: 34204000.00
AGEN balance_sheet (annual, 2025-12-31) — Accounts Payable: 82987000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 82987000.00
AGEN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1831000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1831000.00
AGEN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -47468000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -47468000.00
AGEN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1911740000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1911740000.00
AGEN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 234000.00
AGEN balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 121554000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 121554000.00
AGEN income_statement (annual, 2025-12-31) — Basic Average Shares: 29734000.00
AGEN income_statement (annual, 2025-12-31) — Basic EPS: 0.00
AGEN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 44071000.00
AGEN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5170000.00
AGEN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 0.00
AGEN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 0.00
AGEN cash_flow (annual, 2025-12-31) — Capital Expenditure: -6000.00
AGEN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 11244000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 11244000.00
AGEN balance_sheet (annual, 2025-12-31) — Capital Stock: 353000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 353000.00
AGEN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2998000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2998000.00
AGEN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2998000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2998000.00
AGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 36593000.00
AGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 15374000.00
AGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1194000.00
AGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 780000.00
AGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -77195000.00
AGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -16618000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Account Payable: 23500000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -3340000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 4499000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -8936000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -197000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 10045000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Payable: 23500000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Payable: -3340000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 27999000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -12276000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1260000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 100000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Receivables: -1728000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1679000.00
AGEN cash_flow (annual, 2025-12-31) — Change In Working Capital: 27334000.00
AGEN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3810000.00
AGEN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1728000.00
AGEN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1679000.00
AGEN cash_flow (annual, 2025-12-31) — Changes In Cash: -39408000.00
AGEN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -464000.00
AGEN balance_sheet (annual, 2025-12-31) — Common Stock: 353000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Common Stock: 353000.00
AGEN balance_sheet (annual, 2025-12-31) — Common Stock Equity: -271111000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -271111000.00
AGEN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 36136000.00
AGEN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 8611000.00
AGEN cash_flow (annual, 2025-12-31) — Common Stock Payments: -87000.00
AGEN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
AGEN balance_sheet (annual, 2025-12-31) — Construction In Progress: 56000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 56000.00
AGEN income_statement (annual, 2025-12-31) — Cost Of Revenue: 80360000.00
AGEN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 7511000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 25117000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 25117000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Assets: 133436000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Assets: 133436000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1136000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1136000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Debt: 44655000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Debt: 44655000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 45791000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 45791000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
AGEN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
AGEN balance_sheet (annual, 2025-12-31) — Current Liabilities: 323489000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 323489000.00
AGEN balance_sheet (annual, 2025-12-31) — Current Notes Payable: 34198000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 34198000.00
AGEN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 9999000.00
AGEN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 597000.00
AGEN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 9999000.00
AGEN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 597000.00
AGEN income_statement (annual, 2025-12-31) — Diluted Average Shares: 29734000.00
AGEN income_statement (annual, 2025-12-31) — Diluted EPS: 0.00
AGEN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -101000.00
AGEN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -10632000.00
AGEN balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Non Current: 15435000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Non Current: 15435000.00
AGEN income_statement (annual, 2025-12-31) — EBIT: 52190000.00
AGEN income_statement (quarterly, 2025-12-31) — EBIT: 5407000.00
AGEN income_statement (annual, 2025-12-31) — EBITDA: 62189000.00
AGEN income_statement (quarterly, 2025-12-31) — EBITDA: 6004000.00
AGEN income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -26345000.00
AGEN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 47000.00
AGEN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 4000.00
AGEN cash_flow (annual, 2025-12-31) — End Cash Position: 4710000.00
AGEN cash_flow (quarterly, 2025-12-31) — End Cash Position: 4710000.00
AGEN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 36593000.00
AGEN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 15374000.00
AGEN cash_flow (annual, 2025-12-31) — Free Cash Flow: -77201000.00
AGEN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -16618000.00
AGEN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -387000.00
AGEN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -100924000.00
AGEN cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
AGEN income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 100924000.00
AGEN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
AGEN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -439000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -439000.00
AGEN income_statement (annual, 2025-12-31) — General And Administrative Expense: 54392000.00
AGEN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 12295000.00
AGEN balance_sheet (annual, 2025-12-31) — Goodwill: 24092000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Goodwill: 24092000.00
AGEN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 27129000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 27129000.00
AGEN balance_sheet (annual, 2025-12-31) — Gross PPE: 70682000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 70682000.00
AGEN income_statement (annual, 2025-12-31) — Gross Profit: 33836000.00
AGEN income_statement (quarterly, 2025-12-31) — Gross Profit: 26693000.00
AGEN income_statement (annual, 2025-12-31) — Interest Expense: 55273000.00
AGEN income_statement (quarterly, 2025-12-31) — Interest Expense: 16019000.00
AGEN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 55273000.00
AGEN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 16019000.00
AGEN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1175000.00
AGEN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 272000.00
AGEN balance_sheet (annual, 2025-12-31) — Invested Capital: -226456000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Invested Capital: -226456000.00
AGEN cash_flow (annual, 2025-12-31) — Investing Cash Flow: 1194000.00
AGEN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 780000.00
AGEN balance_sheet (annual, 2025-12-31) — Investments And Advances: 24277000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 24277000.00
AGEN balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 24277000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 24277000.00
AGEN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 36136000.00
AGEN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 8611000.00
AGEN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 12500000.00
AGEN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 10000000.00
AGEN balance_sheet (annual, 2025-12-31) — Land And Improvements: 10056000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 10056000.00
AGEN balance_sheet (annual, 2025-12-31) — Leases: 23605000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Leases: 23605000.00
AGEN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 10108000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 10108000.00
AGEN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 10108000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 10108000.00
AGEN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 12500000.00
AGEN cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 10000000.00
AGEN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -10151000.00
AGEN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2992000.00
AGEN balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 24277000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 24277000.00
AGEN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 29221000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 29221000.00
AGEN balance_sheet (annual, 2025-12-31) — Minority Interest: -6750000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Minority Interest: -6750000.00
AGEN income_statement (annual, 2025-12-31) — Minority Interests: 3198000.00
AGEN income_statement (quarterly, 2025-12-31) — Minority Interests: 34000.00
AGEN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 36049000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 8611000.00
AGEN balance_sheet (annual, 2025-12-31) — Net Debt: 41657000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Net Debt: 41657000.00
AGEN income_statement (annual, 2025-12-31) — Net Income: 115000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Income: -10578000.00
AGEN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -101000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -10632000.00
AGEN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -3083000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -10612000.00
AGEN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 115000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -10578000.00
AGEN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 115000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -10578000.00
AGEN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -3083000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -10612000.00
AGEN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -3083000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -10612000.00
AGEN income_statement (annual, 2025-12-31) — Net Interest Income: -55273000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Interest Income: -16019000.00
AGEN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 841000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 779000.00
AGEN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2349000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 7008000.00
AGEN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2349000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 7008000.00
AGEN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -55273000.00
AGEN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -16019000.00
AGEN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1974000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -292000.00
AGEN balance_sheet (annual, 2025-12-31) — Net PPE: 23214000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Net PPE: 23214000.00
AGEN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 353000.00
AGEN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 1000.00
AGEN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -298240000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -298240000.00
AGEN balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 15435000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 15435000.00
AGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 1143000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (annual, 2025-12-31) — Normalized EBITDA: -39122000.00
AGEN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 6004000.00
AGEN income_statement (annual, 2025-12-31) — Normalized Income: -101196000.00
AGEN income_statement (quarterly, 2025-12-31) — Normalized Income: -10578000.00
AGEN balance_sheet (annual, 2025-12-31) — Notes Receivable: 5179000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 5179000.00
AGEN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -77195000.00
AGEN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -16618000.00
AGEN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -100374000.00
AGEN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -386000.00
AGEN income_statement (annual, 2025-12-31) — Operating Income: -20556000.00
AGEN income_statement (quarterly, 2025-12-31) — Operating Income: 14398000.00
AGEN income_statement (annual, 2025-12-31) — Operating Revenue: 5608000.00
AGEN income_statement (quarterly, 2025-12-31) — Operating Revenue: 3151000.00
AGEN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 35320397.00
AGEN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 35320397.00
AGEN balance_sheet (annual, 2025-12-31) — Other Current Assets: 1089000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1089000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 10457000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 10457000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 169594000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 169594000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -439000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -439000.00
AGEN income_statement (annual, 2025-12-31) — Other Gand A: 54392000.00
AGEN income_statement (quarterly, 2025-12-31) — Other Gand A: 12295000.00
AGEN income_statement (annual, 2025-12-31) — Other Income Expense: 72746000.00
AGEN income_statement (quarterly, 2025-12-31) — Other Income Expense: -8991000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 3037000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3037000.00
AGEN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -51194000.00
AGEN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -12125000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 3307000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 3307000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 169919000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 169919000.00
AGEN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -2220000.00
AGEN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 17354000.00
AGEN balance_sheet (annual, 2025-12-31) — Other Properties: 7744000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Other Properties: 7744000.00
AGEN balance_sheet (annual, 2025-12-31) — Payables: 82987000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Payables: 82987000.00
AGEN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 108104000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 108104000.00
AGEN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
AGEN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
AGEN income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 216000.00
AGEN income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 54000.00
AGEN balance_sheet (annual, 2025-12-31) — Prepaid Assets: 785000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 785000.00
AGEN income_statement (annual, 2025-12-31) — Pretax Income: -3083000.00
AGEN income_statement (quarterly, 2025-12-31) — Pretax Income: -10612000.00
AGEN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 169000.00
AGEN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 47000.00
AGEN balance_sheet (annual, 2025-12-31) — Properties: 0.00
AGEN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
AGEN cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
AGEN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -6000.00
AGEN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
AGEN balance_sheet (annual, 2025-12-31) — Receivables: 7010000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Receivables: 7010000.00
AGEN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 80360000.00
AGEN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 7511000.00
AGEN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 9999000.00
AGEN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 597000.00
AGEN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -10151000.00
AGEN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2992000.00
AGEN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -87000.00
AGEN cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
AGEN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -387000.00
AGEN balance_sheet (annual, 2025-12-31) — Retained Earnings: -2182765000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -2182765000.00
AGEN cash_flow (annual, 2025-12-31) — Sale Of Investment: 841000.00
AGEN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 779000.00
AGEN cash_flow (annual, 2025-12-31) — Sale Of PPE: 359000.00
AGEN cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 1000.00
AGEN income_statement (annual, 2025-12-31) — Selling General And Administration: 54392000.00
AGEN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 12295000.00
AGEN balance_sheet (annual, 2025-12-31) — Share Issued: 35320397.00
AGEN balance_sheet (quarterly, 2025-12-31) — Share Issued: 35320397.00
AGEN income_statement (annual, 2025-12-31) — Special Income Charges: 101311000.00
AGEN income_statement (quarterly, 2025-12-31) — Special Income Charges: 387000.00
AGEN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 13770000.00
AGEN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3461000.00
AGEN balance_sheet (annual, 2025-12-31) — Stockholders Equity: -271111000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -271111000.00
AGEN balance_sheet (annual, 2025-12-31) — Tangible Book Value: -298240000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -298240000.00
AGEN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGEN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGEN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
AGEN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
AGEN balance_sheet (annual, 2025-12-31) — Total Assets: 226798000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Assets: 226798000.00
AGEN balance_sheet (annual, 2025-12-31) — Total Capitalization: -271111000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -271111000.00
AGEN balance_sheet (annual, 2025-12-31) — Total Debt: 55899000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Debt: 55899000.00
AGEN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -277861000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -277861000.00
AGEN income_statement (annual, 2025-12-31) — Total Expenses: 134752000.00
AGEN income_statement (quarterly, 2025-12-31) — Total Expenses: 19806000.00
AGEN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 504659000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 504659000.00
AGEN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 93362000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 93362000.00
AGEN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 181170000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 181170000.00
AGEN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -20169000.00
AGEN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 14398000.00
AGEN income_statement (annual, 2025-12-31) — Total Unusual Items: 101311000.00
AGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
AGEN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 101311000.00
AGEN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AGEN cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 26119000.00
AGEN cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 6023000.00
AGEN balance_sheet (annual, 2025-12-31) — Working Capital: -190053000.00
AGEN balance_sheet (quarterly, 2025-12-31) — Working Capital: -190053000.00
AGEN income_statement (quarterly, 2026-03-31) — +Operating Expense: 6860000.00
AGEN income_statement (quarterly, 2026-03-31) — +Total Revenue: 33736000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 71084000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 6562000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -47893000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1922370000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
AGEN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 37941000.00
AGEN income_statement (quarterly, 2026-03-31) — Basic EPS: 1.03
AGEN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4710000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 10881000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 385000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 34996000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 34996000.00
AGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -993000.00
AGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 68952000.00
AGEN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -35950000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -11880000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -3080000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -706000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Payable: -11880000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -14960000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -3403000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4731000.00
AGEN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -23800000.00
AGEN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -4731000.00
AGEN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 32009000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Common Stock: 385000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -221221000.00
AGEN cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 7419000.00
AGEN cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -27000.00
AGEN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11822000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 31379000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Assets: 95284000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1054000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Debt: 30193000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 31247000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 40000000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 249237000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 24628000.00
AGEN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 583000.00
AGEN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 583000.00
AGEN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 38285000.00
AGEN income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.02
AGEN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 39172000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Non Current: 15776000.00
AGEN income_statement (quarterly, 2026-03-31) — EBIT: 53875000.00
AGEN income_statement (quarterly, 2026-03-31) — EBITDA: 54458000.00
AGEN income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -1350000.00
AGEN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -11000.00
AGEN cash_flow (quarterly, 2026-03-31) — End Cash Position: 36708000.00
AGEN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -993000.00
AGEN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -35950000.00
AGEN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: 40379000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -437000.00
AGEN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 6860000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Goodwill: 24092000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 27051000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 70298000.00
AGEN income_statement (quarterly, 2026-03-31) — Gross Profit: 21914000.00
AGEN income_statement (quarterly, 2026-03-31) — Interest Expense: 14669000.00
AGEN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 14669000.00
AGEN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 188000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Invested Capital: -191028000.00
AGEN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 68952000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 22927000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 22927000.00
AGEN cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 7419000.00
AGEN cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
AGEN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9827000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9827000.00
AGEN cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
AGEN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -8440000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 22927000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Minority Interest: -6762000.00
AGEN income_statement (quarterly, 2026-03-31) — Minority Interests: 20000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 7392000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Income: 39226000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 39172000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 39206000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 39226000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 39226000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 39206000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 39206000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Interest Income: -14669000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 7000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -8440000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -8440000.00
AGEN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -14669000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 68917000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Net PPE: 22405000.00
AGEN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 28000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -248272000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 15776000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 14079000.00
AGEN income_statement (quarterly, 2026-03-31) — Normalized Income: 14998600.00
AGEN balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 0.00
AGEN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -35950000.00
AGEN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -40379000.00
AGEN income_statement (quarterly, 2026-03-31) — Operating Income: 15054000.00
AGEN income_statement (quarterly, 2026-03-31) — Operating Revenue: 4591000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 38521761.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2038000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5565000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 115527000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -437000.00
AGEN income_statement (quarterly, 2026-03-31) — Other Gand A: 6860000.00
AGEN income_statement (quarterly, 2026-03-31) — Other Income Expense: 38821000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2959000.00
AGEN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -14217000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3013000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 154232000.00
AGEN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -208000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Properties: 70298000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Other Receivables: 7500000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Payables: 71084000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 102463000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
AGEN income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 54000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 4188000.00
AGEN income_statement (quarterly, 2026-03-31) — Pretax Income: 39206000.00
AGEN cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 55000.00
AGEN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
AGEN balance_sheet (quarterly, 2026-03-31) — Receivables: 14062000.00
AGEN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 11822000.00
AGEN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 583000.00
AGEN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -8440000.00
AGEN cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -27000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -2143539000.00
AGEN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 7000.00
AGEN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 28000.00
AGEN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 6860000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Share Issued: 38521761.00
AGEN income_statement (quarterly, 2026-03-31) — Special Income Charges: 40379000.00
AGEN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1098000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -221221000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -248272000.00
AGEN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 16151600.00
AGEN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
AGEN balance_sheet (quarterly, 2026-03-31) — Total Assets: 186456000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -221221000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Total Debt: 41074000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -227983000.00
AGEN income_statement (quarterly, 2026-03-31) — Total Expenses: 18682000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 414439000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 91172000.00
AGEN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 165202000.00